ACROBiosystems - Survey NA

EDITORIAL SECTION

KNOWLEDGE BANK

  • Articles

    Forgotten Biology: The Missing Link Behind Trial Outcomes

    Clinical trials are often described as the science of uncertainty and that uncertainty is expected It is how evidence is built However not all uncertainty is scientific In many cases it arises when the biological context of an intervention is not carried through into the study population

TOP ARTICLES

press releasesRead more...

Lynk Pharmaceuticals Announces NMPA Approval of LNK01004 Ointment's Phase II Clinical Trial for the Treatment of Vitiligo and Chronic Hand Eczem

Lynk Pharmaceuticals Co Ltd Lynk Pharmaceuticals a clinicalstage innovative drug development company focused on immune and inflammatory diseases today announced that its internally developed Class

Eisai and CaringKind Launch New Initiative to Address Mealtime and Nutrition Needs for People Living with Alzheimer's Disease and Related Dementias

Eisai Inc today announced the expansion of its Magnolia Meals at Home program to support the Alzheimers disease and related dementias ADRD community through a new initiative developed in collaboration with CaringKind

Sino Biological’s Cell-Free Protein Synthesis Supports Tencent AI for Life Sciences Lab’s Protein Design Study Published in Nature Communications

Sino Biological Inc Shenzhen Stock Exchange SZ has announced that its gene synthesis and cellfree protein expression workflow was used in a recent study by Tencent AI for Life Sciences Lab published in Nature

Spherix Data Reveals Explosive Demand for Wegovy Pill as $100B Weight Loss Race Intensifies

Spherix the leading independent market intelligence and advisory firm for the global life sciences industry today announced new research highlighting how the race to dominate the billion weight loss market is accelerating

01 - 02

Jun 2026

Future Pharma 2026

Renaissance Seaport District, Boston, MA, USA

02 - 04

Jun 2026

CPHI Americas 2026

Pennsylvania Convention Center, Philadelphia, USA

04 - 05

Jun 2026

Pharmac South 2026

Chennai Trade Centre, Nandambakkam, India

04 - 06

Jun 2026

09 - 11

Jun 2026

5th World ADC Summit South Korea

COEX Magok Lewest, 143 Magokjungang-ro, Gangseo-gu, Seoul, South Korea

09 - 11

Jun 2026

World TPD & Induced Proximity Summit South Korea

COEX Magok Lewest, 143 Magokjungang-ro, Gangseo-gu, Seoul, South Korea

09 - 11

Jun 2026

World Targeted Therapeutics Summit South Korea

COEX Magok Lewest, 143 Magokjungang-ro, Gangseo-gu, Seoul, South Korea

09 - 10

Jun 2026

ChemE Show 2026

George R. Brown Convention Center, Houston, Texas, USA

LATEST NEWSRead more...

Wockhardt Secures US FDA Approval for ZAYNICH Antibiotic for Complicated Urinary Tract Infections

Wockhardt has received approval from the US Food and Drug Administration FDA for ZAYNICH cefepime and zidebactam a novel intravenous antibiotic for the treatment of adults with complicated urinary tract infections

Pfizer and Innovent Biologics Form Global Oncology Partnership to Advance Cancer Drug Development

Pfizer and Innovent Biologics have entered into a global strategic licensing and collaboration agreement to develop earlystage and newly discovered cancer medicines

Lupin Secures U.S. FDA Approval for Generic Colonoscopy Preparation Tablets

Lupin Limited has received approval from the US Food and Drug Administration FDA for its Abbreviated New Drug Application ANDA for Sodium Sulfate Magnesium Sulfate and Potassium Chloride Tablets g g g

Antengene receives CDE support for Phase III study of ATG-022 in gastric and gastroesophageal junction cancer

Antengene has received approval from the Center for Drug Evaluation CDE of Chinas National Medical Products Administration to begin the pivotal Phase III CLINCH study of ATG for the treatment of CLDNpositive

Kazia Therapeutics expands Phase 1b trial of paxalisib in advanced breast cancer

Kazia Therapeutics has expanded its ongoing Phase b clinical trial of paxalisib in combination with standard treatment therapies for patients with advanced triple negative breast cancer TNBC

Insilico Medicine and Human Longevity Partner to Develop AI Foundation Model for Longevity Science

Insilico Medicine and Human Longevity have announced a multimilliondollar collaboration to codevelop what the companies describe as the industrys first largescale artificial intelligence AI foundation model focused on human longevity science